Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT).
暂无分享,去创建一个
R. Garfein | P. Kerndt | H. Hagan | S. Strathdee | S. Bailey | E. Golub | F. Kapadia | L. Ouellet | I. Williams | A. Swartzendruber | M. Latka | D. Hanson | S. Hudson | H. Thiede
[1] Douglas G. Altman,et al. Assessing the Quality of Randomised Controlled Trials , 2008 .
[2] R. Garfein,et al. Development, description, and acceptability of a small-group, behavioral intervention to prevent HIV and hepatitis C virus infections among young adult injection drug users. , 2007, Drug and alcohol dependence.
[3] Steffanie A Strathdee,et al. A peer-education intervention to reduce injection risk behaviors for HIV and hepatitis C virus infection in young injection drug users , 2007, AIDS.
[4] Nicole Crepaz,et al. Evidence-based HIV behavioral prevention from the perspective of the CDC's HIV/AIDS Prevention Research Synthesis Team. , 2006, AIDS education and prevention : official publication of the International Society for AIDS Education.
[5] B. Branson,et al. A meta-analysis of the effectiveness of alternative HIV counseling and testing methods to increase knowledge of HIV status , 2006, AIDS.
[6] Susan G. Sherman,et al. The role of sexual transmission of HIV infection among injection and non-injection drug users , 2003, Journal of Urban Health.
[7] Lu Yin,et al. HIV Incidence and Factors Contributed to Retention in a 12-Month Follow-up Study of Injection Drug Users in Sichuan Province, China , 2005, Journal of acquired immune deficiency syndromes.
[8] D. Vlahov,et al. Childhood sexual abuse and age at initiation of injection drug use. , 2005, American journal of public health.
[9] D. Metzger,et al. Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users. , 2005, Addiction.
[10] S. Kellerman,et al. Changes in HIV and AIDS in the United States: Entering the third decade , 2005, Current HIV/AIDS reports.
[11] Y. Gilleece,et al. Increased numbers of acute hepatitis C infections in HIV positive homosexual men; is sexual transmission feeding the increase? , 2004, Sexually Transmitted Infections.
[12] A. Lansky,et al. Failure to Return for HIV Test Results Among Persons at High Risk for HIV Infection: Results From a Multistate Interview Project , 2004, Journal of Acquired Immune Deficiency Syndromes.
[13] D. Heckathorn,et al. Extensions of Respondent-Driven Sampling: A New Approach to the Study of Injection Drug Users Aged 18–25 , 2002, AIDS and Behavior.
[14] M. Alter,et al. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention. , 2003, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[15] M. Busch,et al. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. , 2002, The Journal of infectious diseases.
[16] R. Garfein,et al. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. , 2002, American journal of epidemiology.
[17] Douglas G. Altman,et al. Systematic reviews in health care : meta-analysis in context , 2008 .
[18] D. Vlahov,et al. Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective. , 2001, Archives of internal medicine.
[19] P. Bacchetti,et al. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis , 2001, The Lancet.
[20] D. Vlahov,et al. Factors Associated with Adolescent Initiation of Injection Drug Use , 2001, Public health reports.
[21] J. Duchin,et al. Sharing of drug preparation equipment as a risk factor for hepatitis C. , 2001, American journal of public health.
[22] L. Thorpe,et al. Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997-1999. , 2000, The Journal of infectious diseases.
[23] D S Metzger,et al. Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team. , 2000, American journal of epidemiology.
[24] B. Edlin,et al. The effect of syringe exchange use on high-risk injection drug users: a cohort study , 2000, AIDS.
[25] K. Marder,et al. Longitudinal changes in sexual risk behavior among HIV+ and HIV- male injecting drug users. , 1999, The American journal of drug and alcohol abuse.
[26] Heather Miller,et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: a quasi-randomised trial , 1999, The Lancet.
[27] R. Wejstål. Sexual transmission of hepatitis C virus. , 1999, Journal of hepatology.
[28] H. Margolis,et al. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease , 1998 .
[29] F Rhodes,et al. Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial. Project RESPECT Study Group. , 1998, JAMA.
[30] F Rhodes,et al. What about money? Effect of small monetary incentives on enrollment, retention, and motivation to change behaviour in an HIV/STD prevention counselling intervention. The Project RESPECT Study Group. , 1998, Sexually transmitted infections.
[31] R. Booth,et al. Effectiveness of HIV/AIDS interventions on drug use and needle risk behaviors for out-of-treatment injection drug users. , 1998, Journal of psychoactive drugs.
[32] D. Celentano,et al. Preventing HIV infection: the effects of community linkages, time, and money on recruiting and retaining women in intervention groups. , 1998, Journal of women's health.
[33] S. M. Rogers,et al. Adolescent sexual behavior, drug use, and violence: increased reporting with computer survey technology. , 1998, Science.
[34] D. Vlahov,et al. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[35] Douglas D. Heckathorn,et al. Respondent-driven sampling : A new approach to the study of hidden populations , 1997 .
[36] D. Vlahov,et al. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. , 1996, The Journal of infectious diseases.
[37] B. Jovanovic,et al. Risk behavior and HIV seroincidence among out-of-treatment injection drug users: a four-year prospective study. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[38] D. Vlahov,et al. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. , 1996, American journal of public health.
[39] S. Tortu,et al. The impact of providing incentives for attendance at AIDS prevention sessions. , 1994, Public health reports.
[40] H. Wolfe,et al. Preparations for AIDS vaccine trials. Retention, behavior change, and HIV-seroconversion among injecting drug users (IDUs) and sexual partners of IDUs. , 1994, AIDS research and human retroviruses.
[41] R. Valdiserri,et al. A study of clients returning for counseling after HIV testing: implications for improving rates of return. , 1993, Public health reports.
[42] W A Fisher,et al. Changing AIDS-risk behavior. , 1992, Psychological bulletin.
[43] A Munoz,et al. The Alive Study: A Longitudinal Study of HIV-1 Infection in Intravenous Drug Users: Description of Methods , 1991, NIDA research monograph.
[44] D. Vlahov,et al. Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland. , 1990, American journal of epidemiology.
[45] P. Selwyn,et al. Risk factors for human immunodeficiency virus infection in intravenous drug users. , 1989, The New England journal of medicine.
[46] W. El-Sadr,et al. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. , 1987, AIDS.
[47] R. Chaisson,et al. Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. , 1987, American journal of public health.
[48] Y. Hser,et al. Sex differences in addict careers. 1. Initiation of use. , 1987, The American journal of drug and alcohol abuse.